Horizon Investment Services’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.88M Buy
8,391
+88
+1% +$21.9K 0.66% 49
2025
Q4
$2M Sell
8,303
-1,598
-16% -$409K 0.72% 38
2025
Q3
$2.71M Buy
9,901
+983
+11% +$269K 1.02% 30
2025
Q2
$2.3M Buy
8,918
+1,219
+16% +$291K 1.01% 33
2025
Q1
$1.72M Buy
7,699
+656
+9% +$153K 0.84% 34
2024
Q4
$1.61M Buy
+7,043
New +$1.7M 0.68% 42

Other funds holding RMD

Horizon Investment Services's RMD Position: Q1 2026 in Review

Horizon Investment Services increased its ResMed (RMD) stake by 1.1% in Q1 2026, buying an estimated $21.9K and bringing the position to 8,391 shares worth $1.88M. The position accounts for 0.66% of the portfolio, ranked #49.

Horizon Investment Services first reported a position in RMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.71M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Horizon Investment Services held 8,391 shares of ResMed worth $1.88M as of Q1 2026.
  • Horizon Investment Services bought 88 ResMed shares in Q1 2026, an estimated $21.9K.
  • ResMed made up 0.66% of Horizon Investment Services's portfolio in Q1 2026, its #49 holding.
  • Horizon Investment Services first reported a position in ResMed in Q4 2024 and has held it in 6 quarters since.
  • Horizon Investment Services's ResMed position peaked at $2.71M in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Horizon Investment Services's 13F filing for Q1 2026, filed 15 May 2026.